Evidence map›Paper›PMID 39570098›Full record

SynthesisImmunity, inflammation and disease2024

Acceptance-Hesitancy of COVID-19 Vaccination and Factors Affecting It in Adults: Systematic Review Study.

Atieh Darbandi, Maryam Koupaei, Parisa Kiani, Roya Ghanavati, Parisa Najafi, Jalil Hosseini, Mohammad Reza Shokouhamiri, Arezoo Asadi, Roxana Parsapour

Abstract readSystematic Review
In one paragraph

Synthesis in Immunity, inflammation and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Atieh DarbandiMolecular Microbiology Research Center, Shahed University, Tehran, Iran.
Maryam KoupaeiDepartment of Microbiology and Immunology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Parisa KianiDepartment of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Roya GhanavatiSchool of Medicine, Behbahan Faculty of Medical Sciences, Behbahan, Iran.ORCID 0000-0002-3851-0001
Parisa NajafiFaculty of Sports and Exercise Science, University Malaya, Kuala Lumpur, Malaysia.
Jalil HosseiniMen's Health & Reproductive Health Research Centre, Shohada Hospital Tajrish, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad Reza ShokouhamiriDepartment of Mycology and Parasitology, Faculty of Medical Sciences, Golestan University of Medical Sciences, Gorgan, Iran.
Arezoo AsadiEndocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
Roxana ParsapourMen's Health & Reproductive Health Research Centre, Shohada Hospital Tajrish, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

This work was supported by the Shahid Beheshti University of Medical Sciences (Grant Number 43006342).
6 · The paper itself

Abstract

backgroundDespite the advent of vaccines against COVID-19, there is considerable variation in the acceptance and hesitancy towards the vaccination program across different countries. The objective of this study was to ascertain the prevalence of hesitancy and acceptance regarding the use of the vaccine against the novel coronavirus, also known as COVID-19, and to identify the factors that influence these attitudes. MATERIALS AND

methodsAll the cross-sectional studies were retrieved from the PubMed databases, the Web of Science ISI, Scopus, and the Cochrane Library. Papers published in English between 2 November 2019 and 23 May 2023 were subjected to further assessment based on their title, abstract, and main text, with a view to ensuring their relevance to the present study.

resultsFollowing an exhaustive investigation, 59 studies were selected for screening in this systematic review. The most frequently employed method of data collection was the online survey. The study sample comprised 59.12% women and 40.88% men, with ages ranging from 16 to 78 years. The proportion of individuals accepting the vaccine ranged from 13% to 96%, while the proportion of those exhibiting hesitancy ranged from 0% to 57.5%. The primary reasons for accepting the COIVD-19 vaccine were a heightened perception of risk associated with the virus and a general trust in the healthcare system. The most frequently cited reasons for vaccine hesitancy in the context of the ongoing pandemic include concerns about the potential dangers of the vaccines, the rapid pace of their development, the possibility of adverse effects (such as infertility or death), and the assumption that they have been designed to inject microchips. DISCUSSION: A variety of socio-demographic factors are implicated in determining the rate of vaccine acceptance. A number of socio-demographic factors have been identified as influencing vaccine acceptance. These include high income, male gender, older age, marriage, the presence of older children who have been vaccinated and do not have chronic diseases, high education, and health insurance coverage.

conclusionEliminating vaccine hesitancy or increasing vaccine acceptance is a crucial factor that should be addressed through various means and in collaboration with regulatory and healthcare organizations.

Indexed as

COVID-19COVID-19 VaccinesPatient Acceptance of Health CareSARS-CoV-2VaccinationVaccination HesitancyAdolescentAdultAgedCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedYoung AdultCOVID-19 VaccinesCOVID‐19cross‐sectional studiesvaccination hesitancyvaccination refusalvaccine acceptance

Identifiers

PMID39570098
PMCPMC11580281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.